Junpu Intelligent Delivers Customized Insulin Auto-Injector Production Line for Sanofi

China Securities News (Reporter Yang Ye) — On September 16, Ningbo Pia Automation Holding Corp. announced that the intelligent, disposable insulin auto-injector pen production line, customized for the global pharmaceutical giant Sanofi, has recently entered the delivery phase. Once operational, it will have an annual production capacity of 4 million insulin auto-injector pens.

The engineers of Ningbo Pia Automation Holding Corp.'s medical intelligent manufacturing equipment introduced that the production line is highly flexible and intelligent, meeting the demands for high capacity and reliable quality and safety. Each insulin pen production line enforces strict quality control management, utilizing self-developed fully automatic laboratory testing technology for auto-injectors, which ensures high precision, high reliability, and traceability. The production line employs vision inspection technology to maximize product quality assurance. Additionally, to achieve diversified insulin pen production, the integration of a servo handling system enhances the flexibility of the production line and simplifies parameter adjustments, enabling flexible production.

Xie Shilai, General Manager of Ningbo Pia Automation Holding Corp., revealed that relying on the company's global collaborative advantages and utilizing existing project technologies and customer resources, the company has shown strong growth momentum in the medical device sector, continuously securing orders for medical devices and high-value consumables from internationally renowned clients.

It is reported that Ningbo Pia Automation Holding Corp. has over 40 years of industry experience in the field of intelligent manufacturing equipment for medical health. Its Amberg factory in Germany has been providing high-quality, high-output, and highly flexible medical production solutions for globally renowned medical companies such as Sanofi and Gerresheimer for many years, and has completed multiple production lines for insulin injection pens.